Colorectal Cancer

Colorectal Cancer Treatment Outcomes

Patients with gastrointestinal cancer benefit from the coordinated efforts of Cleveland Clinic's multidisciplinary teams, comprising surgeons and physicians from the departments of Colorectal Surgery and General Surgery, Gastroenterology, Interventional Radiology, Medical Oncology and Radiation Oncology. Tailored treatment regimens include adjuvant therapy following surgical resection for patients with tumors at risk for recurrence, as well as systemic therapies for patients with inoperable, incurable advanced disease. Clinical trials provide important treatment options to patients. The data shown here demonstrates superior outcomes in advanced-stage colorectal cancer.

Five-Year Overall Survival of Patients With All Stages of Colon and Rectum Cancer (N = 5214)

2008-2018

Five-Year Overall Survival of Patients With All Stages of Colon vs Rectal Cancer (N = 5212)

2008-2018

Number at Risk Year 1 Year 2 Year 3 Year 4 Year 5
Colon (N = 2879) 2197 1609 1158 804 507
Rectum (N = 2333) 1887 1435 1034 716 414
Five-Year Overall Survival of Patients With Colon and Rectal Cancer by Stage (N = 4808)

2008-2018

Number at Risk Year 1 Year 2 Year 3 Year 4 Year 5
Stage I (N = 1054) 883 720 551 391 243
Stage II (N = 1086) 870 687 520 379 230
Stage III (N = 1646) 1314 997 723 506 303
Stage IV (N = 1022) 700 407 230 126 66
Five-Year Overall Survival of Patients With Colon Cancer by Stage (N = 2653)

2008-2018

Number at Risk Year 1 Year 2 Year 3 Year 4 Year 5
Stage I (N = 527) 429 336 259 184 120
Stage II (N = 671) 520 420 326 249 160
Stage III (N = 800) 631 479 341 234 140
Stage IV (N = 655) 446 247 136 70 40
Five-Year Overall Survival of Patients With Rectal Cancer by Stage (N = 2155)

2008-2018

Number at Risk Year 1 Year 2 Year 3 Year 4 Year 5
Stage I (N = 527) 454 384 292 207 123
Stage II (N = 415) 350 267 194 130 70
Stage III (N = 846) 683 518 382 272 163
Stage IV (N = 367) 254 160 94 56 26